HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Maria Barbui Selected Research

Azoles

10/2014Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Maria Barbui Research Topics

Disease

5Infections
06/2023 - 01/2004
4Neoplasms (Cancer)
12/2022 - 07/2007
3Multiple Myeloma
12/2005 - 01/2002
2B-Cell Lymphoma (Lymphoma, B Cell)
03/2024 - 11/2016
2Lymphoma (Lymphomas)
12/2022 - 02/2018
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 12/2013
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2021 - 01/2021
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2019 - 10/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 06/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2019 - 07/2007
1Meningococcal Infections
01/2023
1Hypertension (High Blood Pressure)
11/2022
1Sepsis (Septicemia)
09/2022
1COVID-19
01/2021
1Mucormycosis
01/2019
1Second Primary Neoplasms (Neoplasms, Second)
10/2018
1Gonorrhea
06/2018
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2015
1Invasive Fungal Infections
10/2014
1Arthritis (Polyarthritis)
04/2014
1Pulmonary Tuberculosis
04/2014
1Disease Progression
12/2005
1Fatigue
06/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2004

Drug/Important Bio-Agent (IBA)

3Rituximab (Mabthera)FDA Link
11/2019 - 12/2013
2Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 06/2018
1axicabtagene ciloleucelIBA
03/2024
1FosfomycinFDA Link
06/2023
14CMenB vaccineIBA
01/2023
1insulin receptor-related receptor (IRR)IBA
01/2023
1VaccinesIBA
01/2023
1Recombinant ProteinsIBA
01/2023
1Protein Isoforms (Isoforms)IBA
12/2022
1Liver X ReceptorsIBA
12/2022
1Immunomodulating AgentsIBA
11/2022
1meropenem and vaborbactamIBA
09/2022
1CefiderocolIBA
09/2022
1tazobactam drug combination ceftolozaneIBA
09/2022
1ceftazidime drug combination avibactamIBA
09/2022
1Monoclonal AntibodiesIBA
11/2021
1tafasitamabIBA
11/2021
1Lenalidomide (CC 5013)FDA Link
11/2021
1AntigensIBA
01/2021
1liposomal amphotericin BFDA Link
01/2019
1isavuconazoleIBA
01/2019
1obinutuzumabIBA
10/2018
1Bendamustine HydrochlorideFDA Link
10/2018
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018
1GalliumIBA
10/2018
1Prednisone (Sone)FDA LinkGeneric
10/2018
1Vincristine (Oncovin)FDA LinkGeneric
10/2018
1TenascinIBA
02/2018
1Glycoproteins (Glycoprotein)IBA
02/2018
1AzolesIBA
10/2014
1posaconazoleFDA Link
10/2014
1Moxifloxacin (Avelox)FDA Link
04/2014
1CytokinesIBA
07/2007
1Hemoglobins (Hemoglobin)IBA
06/2005
1Hepatitis C AntibodiesIBA
01/2004
1RNA (Ribonucleic Acid)IBA
01/2004
1Antineoplastic Agents (Antineoplastics)IBA
06/2003
1Gemtuzumab (Mylotarg)FDA Link
06/2003
1Caspase 3 (Caspase-3)IBA
06/2003
1CalicheamicinsIBA
06/2003

Therapy/Procedure

6Drug Therapy (Chemotherapy)
11/2019 - 12/2005
3Stem Cell Transplantation
01/2021 - 01/2015
3Therapeutics
11/2019 - 01/2015
2Immunotherapy
10/2021 - 11/2019
2Autologous Transplantation
12/2005 - 01/2002
1Hematopoietic Stem Cell Transplantation
01/2019
1Radioimmunotherapy
02/2018
1Radiotherapy
07/2007
1Salvage Therapy
07/2007
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2004